PhRMA Takes Concerns About EU Transparency Plan to U.S. Trade Chief

International Pharmaceutical Regulatory Monitor
A A
PhRMA has asked the Office of the U.S. Trade Representative to put the EU on notice for its plan to publish clinical trial data that currently is treated confidentially.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00